Saliva Sample as a Non-Invasive Specimen for the Diagnosis of Coronavirus Disease-2019 (COVID-19): a Cross-Sectional Study
Detection Principle
NucleicAcid-PCR based
Target
ORF1ab-gene, N-gene
Testing Method Category
WHO method(s)
Testing Method
WHO-1, individual-kit
Testing Method - Additional Info
Kit: Sansure Biotech
Reported Performance
LOD: 200 copies (RT-PCR test) ; Specificity: 98.9% ; Sensitivity: 84.2%
Sample Size
200 patients
Peer-reviewed
yes
Related methods
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements